Xilio Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Xilio Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Xilio Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Xilio Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.1M | 1.3M | 0.84 |
| 2025-06-30 | $783k | 1.2M | 0.68 |
| 2025-03-31 | $822k | 1.1M | 0.72 |
| 2024-12-31 | $862k | 903k | 0.96 |
| 2024-09-30 | $711k | 903k | 0.79 |
| 2024-06-30 | $855k | 903k | 0.95 |
| 2024-03-31 | $975k | 903k | 1.08 |
| 2023-12-31 | $496k | 903k | 0.55 |
| 2023-09-30 | $1.9M | 890k | 2.11 |
| 2023-06-30 | $2.3M | 890k | 2.62 |
| 2023-03-31 | $2.8M | 890k | 3.17 |
| 2022-12-31 | $2.4M | 890k | 2.69 |
| 2022-06-30 | $1.2M | 419k | 2.92 |
| 2022-03-31 | $2.9M | 416k | 7.07 |